ESMO 2026: Prostate cancer roundup

AI-based digital MammaPrint assay predicts recurrence risk and survival in early-stage breast cancer

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

UEG 2026: Improving early detection of colorectal cancer

Using artificial intelligence to improve lung cancer screening and risk prediction

Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancer

CLL TIM risk model predicts infection and treatment need in newly diagnosed chronic lymphocytic leukaemia

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

ASCO 2026: Comment: Multi-cancer earlier detection tests

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer